Home
Conditions
Gastroesophageal Junction Adenocarcinoma

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

131 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

NCT04018872

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +17 more
Locations: Dallas VA Medical Center Dallas, Texas, United States

View Trial Details

Enrolling by Invitation

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence

NCT07139951

Conditions: Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, +5 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Not Yet Recruiting

Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma

NCT07709767

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

NCT07701681

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +17 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

NCT07621484

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Locally Advanced Gastric Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study

NCT07685704

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +8 more
Locations: Xijing Hospital, Air Force Medical University Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

Emotional Distress and Pathologic Response in Locally Advanced Gastric/GEJ Adenocarcinoma

NCT07662070

Conditions: Emotional Distress, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, +1 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Objective Sleep Characteristics and Neoadjuvant Immunotherapy Response in Gastric/GEJ Cancer

NCT07662005

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Pathological Response, +1 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.

NCT07655661

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

NCT07059611

Conditions: Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +1 more
Locations: Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Gastroesophageal Junction Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma trial results

Related conditions